---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-019490"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:35:11.295958+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor sets 2028 targets: revenue >$12B, adj. EPS >$3.50, 20%+ CAGR

## Summary
- 2028 revenue target exceeding $12 billion; adjusted EBITDA above $750 million.
- Adjusted EPS target >$3.50, representing a CAGR of more than 20% from 2024 to 2028.
- Cumulative free cash flow between 2024-2028 expected to exceed $1.3 billion.
- Patient Direct segment expected to outpace the market and strengthen home-based care position.
- Plan includes margin optimization in Products & Healthcare Services and disciplined capital allocation.

## SEC filing metadata
- accession: 0001558370-23-019490
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000155837023019490/0001558370-23-019490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000155837023019490/tmb-20231206x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-019490
- JSON: https://secwatch.observer/filing/0001558370-23-019490.json
- Plain text: https://secwatch.observer/filing/0001558370-23-019490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.